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Summary
 
Cytolytic T cells use two mechanisms to kill virally infected cells, tumor cells, or other poten-
tially autoreactive T cells in short-term in vitro assays. The perforin/granule exocytosis mecha-
nism uses preformed cytolytic granules that are delivered to the target cell to induce apoptosis
and eventual lysis. FasL/Fas (CD95 ligand/CD95)–mediated cytolysis requires de novo protein
synthesis of FasL by the CTL and the presence of the death receptor Fas on the target cell to in-
duce apoptosis. Using a CD8
 
1
 
 CTL clone that kills via both the perforin/granule exocytosis
and FasL/Fas mechanisms, and a clone that kills via the FasL/Fas mechanism only, we have ex-
amined the requirement of intra- and extracellular Ca
 
2
 
1
 
 in TCR-triggered cytolytic effector
function. These two clones, a panel of Ca
 
2
 
1
 
 antagonists, and agonists were used to determine
that a large biphasic increase in intracellular calcium concentration, characterized by release of
Ca
 
2
 
1
 
 from intracellular stores followed by a sustained influx of extracellular Ca
 
2
 
1
 
, is required
for perforin/granule exocytosis. Only the sustained influx of extracellular Ca
 
2
 
1
 
 is required for
FasL induction and killing. Thapsigargin, at low concentrations, induces this small but sustained
increase in [Ca
 
2
 
1
 
]
 
i
 
 and selectively induces FasL/Fas-mediated cytolysis but not granule exocy-
tosis. These results further define the role of Ca
 
2
 
1
 
 in perforin and FasL/Fas killing and demon-
strate that differential Ca
 
2
 
1
 
 signaling can modulate T cell effector functions.
 
U
 
pon recognition of Ag/MHC, a cytolytic T cell
(CTL) is activated to perform many effector func-
tions, including cytokine secretion, receptor modulation,
cytolysis and eventually cell division and proliferation, or
apoptosis and death. CTLs use at least three mechanisms of
killing to lyse virus-infected cells, tumor cells, or poten-
tially autoreactive T cells. The perforin and Fas ligand
(FasL)/Fas
 
1
 
 mechanisms account for all of the killing de-
tected in short term assays in vitro (1) with the TNF-
 
a
 
mechanism requiring 24–48 h (2). The perforin/granule
exocytosis pathway is primarily used to kill virus infected
and tumorigenic cells (3–7) and is characterized by the
pore-forming protein, perforin, and several proteases or
granzymes that are stored in the CTL’s cytolytic granules
(8). Upon Ag/MHC recognition, these proteins are deliv-
ered to the target cell to induce membrane damage, apop-
tosis, and eventually lysis (7, 9, 10). This lethal hit is deliv-
ered with a t
 
1⁄2
 
 of 7–10 min and is both temperature and
Ca
 
2
 
1
 
 dependent (11). The FasL/Fas mechanism of killing
appears not to be involved in eradication of virally infected
cells, but instead plays an important role in eliminating au-
toreactive T cells (12–15). This is evident in mice or
humans that lack FasL or Fas and which develop lymphade-
nopathy and lupus-like autoimmunity (13, 16). Both the per-
forin and the FasL/Fas mechanism require TCR–Ag/MHC
interactions, which trigger perforin/granule exocytosis and
induce FasL expression respectively. Because FasL expres-
sion requires de novo protein synthesis in the T cell, it takes
longer to lyse the target cell than the perforin/granule exo-
cytosis mechanism (17, 18). Once FasL is expressed on the
surface of the T cell it can kill Fas-expressing cells in an
MHC-unrestricted manner (19, 20). Since perforin-mediated
cytolysis involves release of preformed granules whereas FasL/
Fas cytolysis requires induction of gene expression, we asked
whether these effector functions are regulated by different
TCR signaling pathways.
The TCR signal transduction pathways that regulate
perforin and FasL/Fas killing are less well defined than the
multiple pathways identified that regulate IL-2 production
 
1
 
Abbreviations used in this paper:
 
 BLT,
 
 N
 
-
 
a
 
-benzyloxycarbonyl-
 
l
 
-lysine
thiobenzyl
 
; 
 
[Ca
 
2
 
1
 
]
 
i
 
, intracellular Ca
 
2
 
1
 
 concentration; CsA, cyclosporin A;
CTL, cytolytic T cell; ER, endoplasmic reticulum; FasL, fas ligand; FD,
factor dependent; HA, hemagglutinin; NBCS, newborn calf serum;
NDGA, nordihydroguaiaretic acid; NFAT, nuclear factor of activated T cells.
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in CD4
 
1
 
 Th1 cells. The PI3kinase, protein kinase C, Ras/
Raf/Erk, JNK, and Ca
 
2
 
1
 
 signaling pathways have all been
implicated in regulating IL-2 production in CD4
 
1
 
 T cells
(21–24). Calcium signaling regulates growth, death, differ-
entiation, cytotoxicity, and cytokine secretion in T cells
(25–28). Several Ca
 
2
 
1
 
-sensitive transcriptional regulators,
including NF-
 
k
 
B (29), Jun kinase (JNK) (30), and NFAT
(nuclear factor of activated T cells; reference 31) participate
in varying combinations to regulate growth cytokines such
as IL-2, IL-4, and GM-CSF and inflammatory cytokines such
as IL-1, IL-6, IL-8, and TNF (28–31). More recently, sev-
eral groups have reported that tyrosine kinases such as
ZAP70 and PI3K are involved in regulating FasL expres-
sion (32–34). A sustained rise in intracellular Ca
 
2
 
1
 
 concen-
tration ([Ca
 
2
 
1
 
]
 
i
 
) can activate calcineurin, a Ca
 
2
 
1
 
-dependent,
cyclosporin A (CsA)–sensitive serine/threonine phosphatase
that dephosphorylates the transcription factor NFAT (28).
Once dephosphorylated, NFAT migrates to the nucleus,
where it associates with Jun and Fos to promote transcrip-
tion of a host of immunoregulatory genes (31). Calcium
regulation of NFAT translocation in and out of the nucleus
and transcription of an IL-2 reporter gene has been visual-
ized at the single cell level (35). The importance of Ca
 
2
 
1
 
 in
lymphocyte activation is evident from the effectiveness of
the immunosuppressant CsA (BIOMOL Research Labs.,
Plymouth Meeting, PA) and the finding that patients with
lymphocytes defective in Ca
 
2
 
1
 
 signaling suffer from pri-
mary immunodeficiency (36).
Classical studies performed by Gray and co-workers re-
corded the spatial and temporal aspects of Ca
 
2
 
1
 
 signaling in
CTLs after TCR engagement (37–40). This TCR trigger-
ing led to a two component increase in [Ca
 
2
 
1
 
]
 
i
 
 due from an
initial release of Ca
 
2
 
1
 
 from intracellular stores followed by a
sustained influx of extracellular Ca
 
2
 
1
 
 (37). Additional stud-
ies demonstrated that extracellular Ca
 
2
 
1
 
 was required for
TCR-triggered serine esterase release (41), and CTLs with
 
z 
 
chain mutations, defective in Ca
 
2
 
1
 
 signaling, were inca-
pable of killing target cells (42). Confounding these studies
were reports of a Ca
 
2
 
1
 
-independent mechanism of killing
(43, 44), which was eventually shown to be mediated by
FasL/Fas interactions (17). Although discovering Fas solved
the mystery concerning an alternative mechanism of killing
used by CTLs, it did not resolve the role of Ca
 
2
 
1
 
 used by
these two mechanisms of cytotoxicity.
We have generated a series of IL-2–dependent, Ag-inde-
pendent clones (CTL-FDs) that have lost the ability to kill
via the perforin/granule exocytosis mechanism of killing,
although they contain functional perforin and granzymes.
These variants have retained the ability to kill via the FasL/
Fas mechanism of killing and they secrete IFN-
 
g
 
. Using
these clones or an altered peptide ligand, we have shown
that distinct TCR signaling events activate perforin versus
FasL/Fas killing (45, 46). In examining the parental 14-7
and the variant 14-7FD clones, we discovered that bypass-
ing early TCR signaling events with phorbol ester and
Ca
 
2
 
1
 
 ionophore could trigger granule exocytosis in the
variant clone. In addition, CsA inhibited FasL/Fas killing
but not perforin killing. This evidence and the fact that 14-
7FD did not display the characteristic biphasic Ca
 
2
 
1
 
 re-
sponse after TCR engagement led us to further examine
the role of intracellular and extracellular Ca
 
2
 
1
 
 in perforin
and FasL/Fas mediated cytotoxicity. 
In this paper, we report that a large biphasic Ca
 
2
 
1
 
 re-
sponse is required for perforin killing, whereas a smaller
sustained Ca
 
2
 
1
 
 influx is sufficient for FasL induction and
killing. We also show that replacing the large [Ca
 
2
 
1
 
]
 
i
 
 flux
in 14-7FD with ionomycin or thapsigargin while stimulat-
ing with PMA is enough to trigger perforin granule/exo-
cytosis cytotoxicity. Extracellular Ca
 
2
 
1
 
 was required for
both perforin and FasL/Fas killing. Lastly, we demonstrate
that differential Ca
 
2
 
1
 
 signaling can activate FasL/Fas versus
perforin killing. These findings should provide insight into
the role of Ca
 
2
 
1
 
 in activation of differential TCR signaling
pathways.
 
Materials and Methods
 
Cell Lines.
 
The L1210Fas
 
1
 
 (H-2d) (17) and the L1210Fas-
(H-2d) (47), target cells were maintained in DMEM (4.5 g/liter
glucose) supplemented with 10% (vol/vol) heat inactivated FCS
(GIBCO BRL, Gaithersburg, MD), 2 mM glutamine, 5 
 
3 
 
10
 
2
 
5
 
M 2-ME, and antibiotics (10 U/ml penicillin G and 10 
 
m
 
g/ml
streptomycin sulfate).
 
T Lymphocyte Clones.
 
T lymphocyte clones, 14-7, 11-1, and
14-13, (48) were stimulated in vitro with influenza A/JAPAN/57
virus infected, 
 
g
 
-irradiated (2,000 rad) BALB/c spleen cells every
7 d in the presence of 10 U/ml human rIL-2 (Biosource Interna-
tional, Inc., Camarillo, CA) in complete media: Iscove’s media
(GIBCO BRL, Gaithersburg, MD), 10% heat inactivated FCS
(HIFCS, Hyclone Laboratories, Logan, UT), 2 mM glutamine
and 5 
 
3 
 
10
 
2
 
5
 
 M 2-ME. The 14-7FD clone was seeded once a
week at 0.5 
 
3 
 
10
 
6
 
 cells/5ml of complete medium and split 1:2 af-
ter 3.5 d in medium containing 30 U/ml human rIL-2.
 
Reagents.
 
Ionomycin (1 M stock in DMSO), thapsigargin (1 M
stock in DMSO; reference 49), PMA (1 M stock in DMSO),
nordihydroguaiaretic acid (NDGA; reference 50) (1M stock in
DMSO), EGTA (100 mM stock in dH20, pH 7.8), NiCl2 (10 M
stock in BSS buffer [140 mM NaCl, 3 mM KCl, 1 mM CaCl
 
2
 
,
1 mM MgCl
 
2
 
, 0.1% glucose, 1% NBCS, 10 mM Hepes, at a final
pH of 7.4]), and emetine (1 mg/ml stock in EtOH) were all
obtained from Sigma Chemical Co., (St. Louis, MO). SK&F-
96365 (1 M stock in dH2O; reference 51) and nifedipine (1 M
stock in DMSO; reference 52) were obtained from Calbiochem
(La Jolla, CA).
Anti-FasL antibody, #F37720, was purchased from Transduc-
tion Laboratories (Lexington, KY).
 
Flow Cytometry.
 
10
 
6
 
 cells/ml were mock stimulated and were
stimulated with plate-bound anti-CD3
 
e
 
 (145-2C11; reference
53) at 5 
 
m
 
g/ml in the presence or absence of various Ca
 
2
 
1
 
 antag-
onists for 6 h in MEM, 1% FCS, 2 mM Gln, and 50 
 
m
 
M 2-ME.
T cells were collected, transferred to a round-bottomed microti-
ter plate, centrifuged, and resuspended in 50 
 
m
 
l of Fas.Fc at 10
 
m
 
g/ml for 30 min on ice in PBS with 1% newborn calf serum
(NBCS). T cells were washed two times, incubated for 30 min
with a biotinylated goat anti–human IgG (5 
 
m
 
g/ml; Southern
Biotechnology Associates, Birmingham, AL), washed two more
times, and incubated in the dark for 30 min with Streptavidin R-PE
(5 
 
m
 
g/ml; Caltag Labs., Burlingame, CA), and then washed three
times in PBS with 1% NBCS and analyzed on a FACScan
 
Ò
 
 (Bec-
ton Dickinson, Mountain View, CA). 
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Intracellular Ca
 
2
 
1
 
 Mobilization Studies.
 
CTL clones were Fi-
coll purified 4 d after in vitro stimulation and 10
 
6
 
 CTL/ml were
incubated with 1 
 
m
 
M Indo-1 for 1 h, and then washed 3 times in
BSS buffer to remove free dye. CTLs were stimulated with 90 
 
m
 
l
of 1.0 mg/ml anti-CD3
 
e
 
 mAb (145-2C11) or with various con-
centrations of thapsigargin or ionomycin at 37
 
8
 
C and the ratio of
398:480 was measured over time. Excitation was at 340 nm in an
SLM 8000 Spectrafluorometer (SLM Aminco, Urbana, IL) in the
T format. Calibration was conducted as previously described (40).
N-a-benzyloxycarbonyl-l-lysine thiobenzyl Esterase Assay. Exocyto-
sis of cytolytic granules was measured by the N-a-benzyloxycar-
bonyl-l-lysine thiobenzyl (BLT) esterase (granzyme A) activity in
the supernatant of stimulated T cells. 96-well PVC round-bot-
tomed plates (Dynatech, Chantilly, VA) were coated with 50 ml of
5 mg/ml mAb to CD3e (145-2C11) for 30 min at room temper-
ature. Plates were washed twice with PBS12% NBCS before
plating 14-7 and 14-7FD at 5 3 104 cells/well in quadruplicates.
PMA, ionomycin, or thapsigargin were added at various concentra-
tions and combinations to the appropriate wells so that the total
volume was 100 ml. The plate was spun for 1 min at 250 g before
incubating the plate at 378C for 4 h. 30 ml of the supernatants
were harvested and assayed for BLT esterase activity as previously
described (41), adapted for a 96-well microtiter plate. After 30
min, absorbance values at 405 nm were determined by reading
the plate on a Bio-Tek EL-340 ELISA reader (Bio-Tek Instru-
ments, Burlington, VT) at an OD of 405 nm. All experiments
were performed in quadruplicate. Total release was determined
by lysing the CTL in 1% Triton X-100. Spontaneous release was
,20% for all experiments.
51Cr–release Cytotoxicity Assay. Target cells were incubated
with sodium 51chromate for 3 h at 378C. Target cells were
washed three times, mock treated, or sensitized with the hemag-
glutinin (HA)529–537 (IYATVAGSL) peptide (0.01 mM; refer-
ence 54) before plating at 104 target cells/well. In all experiments
14-7, 11-1, 14-13, and 14-7FD were added at an E/T of 5:1 in
round-bottomed plates, spun for 1 min at 250 g, and incubated at
378C in a CO2 incubator. Anti-FasL antibody was added to T
cells at 5 mg/ml for 15 min at room temperature before plating.
Supernatants (100 ml) were harvested at 4 h for the perforin kill-
ing experiments and at 6–8 h for the FasL/Fas killing experiments
from each well and counted on a gamma counter (Isomedic; ICN
Biomedical, Huntsville, AL). All experiments were performed in
quadruplicate. Spontaneous release was ,10% in all experiments.
Percentage of specific lysis was calculated as follows:
Results
Anti-CD3e Effectively Stimulates Perforin/Granule Exocyto-
sis and FasL/Fas Cytotoxicity in 14-7 and 14-7FD. We have
previously reported that distinct TCR signaling events trig-
ger perforin versus FasL/Fas cytotoxicity and IFN-g pro-
duction (45, 46). Ag/MHC complexes trigger perforin/
granule exocytosis and induce FasL/Fas killing in 14-7, but
only FasL/Fas killing in 14-7FD (46). We had also ob-
% specific granule exocytosis 100   ´
exp. release O.D. spontaneous release O.D. –
total release O.D. spontaneous release O.D. –
------------------------------------------------------------------------------------------- èø
æö
=
% specific  Cr release
51
100   ´
experimental release cpm spontaneous release cpm –
total cpm spontaneous release cpm –
-------------------------------------------------------------------------------------------------------- èø
æö
=
served that plate-bound anti-CD3e triggered granule exo-
cytosis and IFN-g production in 14-7, whereas it only
stimulated IFN-g production in 14-7FD. Since we planned
to use anti-CD3e in our Ca21 measurements, we wanted
to confirm that soluble anti-CD3e paralleled the Ag/MHC
response in the CTL killing assays. Fig. 1 shows that anti-
CD3e works in a soluble but not a plate-bound fashion to
trigger 14-7 to kill via the perforin mechanism (Fig. 1 a).
Anti-CD3e works both in solution and when plate-bound
to trigger granule exocytosis in the presence or absence of
target cells in 14-7 but not in 14-7FD (Fig. 1 b). In addition,
anti-CD3e induces both 14-7 and 14-7FD to lyse targets
via the FasL/Fas mechanism (Fig. 1 c). In all perforin and
granule exocytosis experiments, the CTLs were pretreated
with 1 mg/ml emetine, an irreversible protein synthesis in-
hibitor (55), for 5 min before the start of the assay to pre-
vent FasL induction or production of granzyme A (56). In
agreement with our previous work, anti-CD3e stimulated
14-7FD to kill via the FasL/Fas mechanism only (Fig. 1, a–c).
These results demonstrate that soluble anti-CD3e could
substitute for Ag/MHC to trigger perforin and FasL/Fas
cytotoxicity in our model system.
Anti-CD3e Stimulation Induces Qualitatively and Quantita-
tively Distinct Ca21 Signals in 14-7 and 14-7FD. We have
previously reported that 14-7 and 14-7FD differ dramati-
cally in their TCR-stimulated total Ca21 response (46), but
in that study we did not distinguish between the intracellu-
lar Ca21 release and extracellular Ca21 influx components
Figure 1. Anti-CD3e stimula-
tion of perforin/granule exocy-
tosis and FasL/Fas killing. 14-7
and 14-7FD were incubated
with either mock treated or pep-
tide antigen HA529–537 (0.01
mM) pulsed target cells at an ef-
fector to target ratio of 5:1. For
anti-CD3e wells, soluble 145-
2C11 (5 mg/ml) was added or
the plate was coated with 5 mg/
ml 145-2C11 for 30 min at
room temperature before addi-
tion of the CTL or the target.
(a) 51Cr cytolysis assay with
L1210Fas- target. (b) BLT-esterase
assay with supernatants from a and from CTL stimulated in the absence of
target cells. (c) 51Cr release assay with L1210Fas1 target.1060 Ca21 Signaling Modulates CTL Effector Functions
of the response. We next examined the role intra- and ex-
tracellular Ca21 played in TCR signaling in 14-7 and 14-
7FD. 14-7 has a resting Ca21 level of z50 nM, which
peaks at 2 mM within 30 s of TCR stimulation and is sus-
tained at z1 mM for at least 6 min (Fig. 2 a). This TCR-
stimulated biphasic Ca21 profile is very similar to that ob-
served by others (37, 57, 58). In contrast, 14-7FD has a
much higher resting level of [Ca21]i than does 14-7, be-
tween 80 and 300 nM (Fig. 2 b). When stimulated with
anti-CD3e, 14-7FD does not undergo the characteristic
Ca21 response seen in 14-7, but has a slow sustained in-
crease in [Ca21]i levels (Fig. 2 b). To measure the contribu-
tion of released intracellular Ca21 to the rise in [Ca21]i, we
used EGTA to chelate extracellular Ca21. When 14-7 was
stimulated through the TCR in the presence of EGTA, the
intracellular release component was easily detected (Fig. 2 c).
In comparison, when 14-7FD was stimulated with anti-
CD3e in the presence of EGTA, little to no intracellular
release component was detected (Fig. 2 d). To determine
the source of the increase in [Ca21]i, we did the converse of
the previous experiment and stimulated 14-7FD through the
TCR and then added EGTA. In 14-7, addition of EGTA
after stimulation led to a reduction in [Ca21]i with a return
to baseline over the course of z45 s (Fig. 2 e). In compari-
son, addition of EGTA after anti-CD3e stimulation of 14-
7FD resulted in an almost immediate reduction in [Ca21]i
(Fig. 2 f). The inorganic Ca21 blocker Ni21 gave very sim-
ilar results (data not shown). These results suggest that for
14-7FD the increase in [Ca21]i is almost exclusively due to
influx, apparently occurring in the presence of very little to
no release of intracellular Ca21. These results demonstrate
that Ca21 signaling in 14-7 and 14-7FD are qualitatively
and quantitatively distinct and provide a correlation be-
tween the differential Ca21 response and the ability to kill
via the perforin/granule exocytosis or FasL/Fas mecha-
nism, respectively (Figs. 1 and 2). 
Release of Intracellular Ca21Induces Influx of Extracellular
Ca21 in 14-7FD. We next wanted to dissect the Ca21
signaling mechanism in 14-7FD. We hypothesized that ei-
ther there was a defect in the TCR signaling pathway lead-
ing to intracellular Ca21 release or that there was a failure
of intracellular released Ca21 to open plasma membrane Ca21
channels. In many cell types extracellular Ca21 influx is ini-
tiated by the release of intracellular Ca21 stores (59–61). To
test whether intracellular Ca21 release could activate the
Ca21 entry pathway in 14-7FD, we used thapsigargin, a
microsomal Ca21 pump inhibitor, to deplete intracellular
Ca21 stores (49, 59, 62). Thapsigargin induces Ca21 release
by inhibiting an endoplasmic reticulum(ER) membrane
Ca21 ATPase pump that constantly pumps Ca21 back into
the ER (49). Thapsigargin induced the release of intracellu-
lar Ca21 when extracellular Ca21 was absent (Fig. 3 a) in
14-7FD. This intracellular Ca21 release induced influx of
extracellular Ca21, as shown by the fact that addition of
EGTA inhibited extracellular Ca21 influx (Fig. 3 b). These
data provide evidence that differential TCR signaling re-
sponse in 14-7FD lies upstream of ER Ca21 release, not in
intracellular Ca21–induced extracellular Ca21 influx.
Ca21 Channel Antagonists Inhibit Perforin/Granule Exocyto-
sis and FasL/Fas-mediated Cytotoxicity. This differential Ca21
signaling in 14-7 and 14-7FD prompted us to further de-
Figure 2. Anti-CD3e induction of Ca21 mobilization and influx in 14-7
and 14-7FD. Anti-CD3e (145-2C11) (45 mg/ml) was used to trigger 14-7
and 14-7FD Ca21 mobilization, and influx was monitored by indo-1 flu-
orescence. EGTA (5 mM) was used to examine the intra- and extracellu-
lar release components of the Ca21 signaling pathways in 14-7 (c, e) and
14-7FD (d, f). EGTA was added before (c and e) or after (d and f) anti-
CD3e addition.
Figure 3. Thapsigargin (Tg) induction of intracellular Ca21 release and
Ca21 influx in 14-7FD. 5 mM EGTA was added before (a) or after (b)
stimulation of 14-7FD with 100 nM thapsigargin.1061 Esser et al.
fine the extracellular and intracellular Ca21 requirements
for perforin and FasL/Fas killing. Several groups have ex-
amined the effects of Ca21 channel antagonists and Ca21
signaling in CTL-mediated killing (37, 41, 42). Since the
FasL/Fas-based mechanism of killing was not discovered
until 1993 (17), we sought to reexamine the ability of vari-
ous Ca21 antagonists to inhibit perforin/granule exocytosis
or FasL/Fas-based killing. The L type channel antagonists
(nifedipine, nitrendipine, and verapamil [52]), T type chan-
nel antagonists (NDGA [50] and SK&F-96365 [51]), calmod-
ulin antagonists (trifluoperazine, W7 [60]), Ca21 chelator
(EGTA), and Ca21 channel blocker Ni21 (26) were examined
for their effects on CTL-mediated cytotoxicity. Trifluoper-
azine and W7 were toxic to the CTL in 4–8-h assays.
EGTA inhibited perforin killing by 14-7 on HA529-pulsed
Fas2 targets (Fig. 4 a) with an IC50 between 1 and 5 mM.
Nifedipine, SK&F-96365, and NDGA inhibited perforin
killing (Fig. 4 a) with IC50s of 50–100 mM, 10–50 mM, and
5–10 mM, respectively (Fig. 4 a). These data demonstrate
the requirement for influx of extracellular Ca21 in perforin
killing and extend the original observations to include new,
more T cell–selective, T type Ca21 channel antagonists.
We tested the same panel of inhibitors for the ability to
inhibit anti-CD3e–triggered granule exocytosis in a target
cell–independent assay. In concordance with our perforin
killing assay, nifedipine, SK&F-96365, NDGA, and EGTA
all inhibited granule exocytosis with similar IC50s as had
been seen in the perforin-killing assay (Fig. 4 b). Ni21 also
inhibited TCR-triggered granule exocytosis (reference 40
and data not shown). These data indicate that extracellular
Ca21 is required for granule exocytosis killing and that both
T and L type selective antagonists can inhibit granule exo-
cytosis.
Historically, the FasL/Fas mechanism of killing was dis-
covered as being a Ca21 independent mechanism of killing
(17). These initial reports were somewhat contradictory to
our finding that CsA inhibited TCR induced FasL/Fas kill-
ing, since it is widely known that CsA acts on calcineurin, a
Ca21-dependent phosphatase (31, 63). Since 14-7/14-7FD
provides a unique system to address this issue, we screened
the same panel of Ca21 antagonists for their ability to block
TCR-induced FasL/Fas killing by 14-7FD. Normally,
TCR engagement induces signals that lead to induction of
the FasL gene. Once FasL is expressed, the CTL can lyse
Fas-expressing targets. EGTA, NDGA, and SK&F-96365
inhibited TCR-induced FasL/Fas killing with IC50s slightly
higher than those required to inhibit perforin killing (Fig. 4
c). In contrast to its effect on perforin killing, nifedipine had
no effect on TCR-induced FasL/Fas killing (Fig. 4 c). To
confirm that extracellular Ca21 was required to induce FasL
expression in 14-7, we screened Ni21 and the panel of in-
hibitors for the ability to inhibit anti-CD3e–induced FasL
expression as detected by flow cytometry. As shown in Fig.
4 d, Ni21, EGTA, SK&F-96365, and NDGA inhibited in-
duction of FasL expression, whereas nifedipine was ineffec-
tive (Fig. 4 d). These data demonstrate that extracellular
Ca21 influx is required for TCR-triggered perforin lysis,
granule exocytosis, and FasL expression, as well as FasL/Fas
killing.
A Large Increase in [Ca21]i Is Required for Perforin Killing.
We next wanted to test whether a Ca21 agonist in combi-
nation either with PMA or a TCR signal could restore the
large increase in [Ca21]i in 14-7FD and therefore restore
perforin/granule exocytosis killing. Using either thapsigar-
gin or ionomycin to induce an increase in [Ca21]i in con-
junction with anti-CD3e or Ag/MHC stimulation, we ex-
amined granule exocytosis (Fig. 5, a–d) and perforin killing
(Fig. 5, e and f). As previously seen, anti-CD3e triggers
granule exocytosis in 14-7, but not in 14-7FD (Fig. 5, a
and b). Both the combination of PMA and ionomycin and
that of PMA and thapsigargin trigger granule exocytosis for
both 14-7 and 14-7FD (Fig. 5, a and b). Ionomycin alone
induces a small yet significant secretion of granzyme A in
14-7FD (Fig. 5 b). We then tested the ability of ionomycin
and thapsigargin to work in combination with anti-CD3e
or Ag/MHC to trigger granule exocytosis. Ionomycin or
thapsigargin with either anti-CD3e or Ag/MHC does not
significantly trigger granule exocytosis in 14-7FD over ion-
omycin or thapsigargin alone (Fig. 5, b and c). These data
indicate that mimicking the large [Ca21]i increase with ion-
omycin or thapsigargin in combination with PMA could
restore perforin/granule exocytosis killing in 14-7FD, whereas
ionomycin or thapsigargin in combination with a TCR
Figure 4. Extracellular Ca21 is required for perforin/granule exocytosis
and FasL/Fas-mediated cytotoxicity. 14-7 (a, b, d) and 14-7FD (c) were
pretreated for 40 min with nifedipine, EGTA, SK&F-96365, NDGA, or
Ni21 at various concentrations before the start of a 51Cr cytolysis assay (a–c) or
before anti-CD3e stimulation (d). 14-7 was incubated with HA529–537
peptide (0.01 mM)–pulsed L1210Fas target in a 51Cr–release assay (a), and
supernatants from a were used to measure granzyme A activity in a gran-
ule exocytosis assay (b). 14-7FD was incubated with HA529–537 peptide
(0.01 mM)–pulsed L1210Fas1 targets in a 51Cr–release assay (c). 14-7 was
stimulated with plate-bound anti-CD3e for 6 h before staining for FasL
with the Fas.Fc fusion protein by flow cytometry (d). All figures are rep-
resentative of at least three separate experiments. 
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signal was not sufficient. This suggests that other TCR sig-
nals in addition to the functional TCR signaling pathways
in 14-7FD and Ca
 
2
 
1
 
 are required for perforin killing by
14-7FD.
To confirm that PMA plus ionomycin or thapsigargin
triggered perforin killing as well as granule exocytosis in
14-7FD, we used the same combinations of ionomycin or
thapsigargin with either PMA or HA529-pulsed Fas
 
2
 
 tar-
gets in a cytotoxicity assay. As previously seen, 14-7 killed
the HA529 pulsed Fas
 
2
 
 target, but 14-7FD did not (Figs. 1
and 5, 
 
e
 
 and 
 
f
 
). Both PMA and ionomycin and PMA and
thapsigargin activated both 14-7 and 14-7FD to kill via the
perforin mechanism (Fig. 5, 
 
e
 
 and 
 
f
 
). Neither HA529 and
ionomycin nor HA529 and thapsigargin significantly in-
duced perforin killing over ionomycin or thapsigargin
alone for 14-7FD (Fig. 5 
 
f
 
). Additionally, ionomycin alone
induced significant killing by both 14-7 and 14-7FD (Fig.
5, 
 
e
 
 and 
 
f
 
). In summary, these data suggest that an increase
in [Ca
 
2
 
1
 
]
 
i
 
 is required for perforin killing.
 
Differential Ca
 
2
 
1
 
 Signaling Activates Perforin Versus FasL/
Fas Killing.
 
Lastly, we wanted to determine if altering
Ca
 
2
 
1
 
 signaling in 14-7 with ionomycin or thapsigargin
could differentially activate FasL/Fas versus perforin killing,
in much the same way that TCR signaling selectively acti-
vates FasL/Fas killing in 14-7FD. First, we examined the
effect of various concentrations of ionomycin or thapsigar-
gin on Ca
 
2
 
1
 
 mobilization and influx in 14-7 to see if we
could find a concentration that mimicked the TCR-induced
Ca
 
2
 
1
 
 response in 14-7FD. Ionomycin gave a concentra-
tion-dependent decrease in the magnitude of the response
(Fig. 6 
 
a
 
). Although the magnitude of the response decreases
with lower amounts of ionomycin, the Ca
 
2
 
1
 
 response
maintained its biphasic appearance (Fig. 6 
 
a
 
). Thapsigargin,
on the other hand, gives a quantitatively and qualitatively
different response than ionomycin (Fig. 6 
 
b
 
). The maximal
response with thapsigargin raises [Ca
 
2
 
1
 
]
 
i
 
 levels to 900 nM,
whereas ionomycin gives a maximal [Ca
 
2
 
1
 
]
 
i
 
 response of
 
z
 
2000 nM (Fig. 6, 
 
a
 
 and 
 
b
 
). The ionomycin [Ca
 
2
 
1
 
]
 
i
 
 re-
sponse in 14-7 looks very similar to the biphasic TCR-trig-
gered response (Figs. 2 
 
a
 
 and 6 
 
a
 
). In comparison, the max-
imal thapsigargin [Ca
 
2
 
1
 
]
 
i
 
 response peaks at 
 
z
 
800 nM and is
maintained at 
 
.
 
700 nM (Fig. 6 
 
b
 
). At lower concentra-
tions, between 10 and 200 nM, the ionomycin [Ca
 
2
 
1
 
]
 
i
 
 re-
sponse is quantitatively lower, but qualitatively similar, re-
Figure 5. A large increase in [Ca21]i is required for perforin/granule
exocytosis killing. 14-7 (a) and 14-7FD (b) were stimulated with plate-
bound anti-CD3e, PMA (25 ng/ml), ionomycin (Ion; 1,000 nM), thapsi-
gargin (Tg; 200 nM), or a combination of PMA and ionomycin, PMA
and thapsigargin, or anti-CD3e plus PMA, ionomycin, or thapsigargin,
respectively, in the absence of target cells, and percentage of granule exo-
cytosis was determined. 14-7 (c, e) and 14-7FD (d, f) were incubated with
HA529–537 peptide (0.01 mM)–pulsed or mock-treated L1210Fas2 tar-
get cells. At the start of the assay PMA, ionomycin, or thapsigargin were
added at the aforementioned concentrations. After 4 h, supernatants were
collected and percentage of granule exocytosis (c and d) and of specific
killing (e and f) was determined.
Figure 6. Thapsigargin or ionomycin induction of perforin versus
FasL/Fas killing. 14-7 was stimulated with 2,000, 1,000, 200, 100, 20, or
10 nM of ionomycin (a) or thapsigargin (b) and [Ca21]i was measured by
indo-1 fluorescence. 14-7 was stimulated with PMA (25 ng/ml) plus dif-
ferent doses of ionomycin or thapsigargin, and granzyme A granule exo-
cytosis was determined (c and d, j), or 14-7 was stimulated with ionomy-
cin or thapsigargin in the absence of PMA and percentage of specific
killing of the L1210Fas1 target was determined (c and d, s). 
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taining a biphasic profile (Fig. 6 a). Thapsigargin, on the
other hand, induces a quantitatively and qualitatively differ-
ent response at lower concentrations than did ionomycin
(Fig. 6 b). Between 1 and 20 nM, thapsigargin induces a
Ca21 response that did not have a fast initial increase, but
induces a slow rise in [Ca21]i (Fig. 6 b). Interestingly, this
Ca21 response looks remarkably like the TCR-triggered
Ca21 response in 14-7FD (Figs. 2 b and 6 b). These results
demonstrate that ionomycin and thapsigargin can induce
quantitatively and qualitatively different Ca21 signals.
We next wanted to determine whether these different
Ca21 signals that had been generated with ionomycin and
thapsigargin have functional consequences in regulating
perforin or FasL/Fas killing. In other words, can we use
ionomycin or thapsigargin to make 14-7 act like 14-7FD
with regard to CTL effector function? Using ionomycin or
thapsigargin at various concentrations, we assayed for gran-
ule exocytosis and lysis of Fas1 targets. At concentrations
up to 100 nM, thapsigargin induces FasL/Fas killing in the
absence of granule exocytosis, but ionomycin does not
(Fig. 6, c and d). The concentrations of thapsigargin that se-
lectively induced FasL/Fas killing corresponds exactly with
those that give a [Ca21]i response that resembles the 14-
7FD TCR-triggered Ca21 response (Figs. 2, b, and 6, b and
d). At higher concentrations of thapsigargin, both perforin/
granule exocytosis and FasL/Fas killing are induced. In
contrast, ionomycin always induced both types of killing
(Fig. 6 d). These data demonstrated that we could make
14-7 behave like 14-7FD by stimulation with low amounts
of thapsigargin.
Fig. 7, a and b, demonstrates that the selective blocking of
perforin cytolysis using nifedipine seen for clone 14-7 (Fig.
4,  a and c) can be extended to additional CD81 CTL
clones, 11-1 and 14-13. The inability of low concentra-
tions of ionomycin to trigger both granule exocytosis (Fig.
7 c) and FasL/Fas cytolysis (Fig. 7 e) also holds for clones
11-1 and 14-13. Low concentrations of thapsigargin trigger
cytolysis (Fig. 7 f) in the absence of significant granule exo-
cytosis (Fig. 7 d). That this cytolysis is FasL/Fas mediated is
demonstrated by inhibition seen in the presence of anti-FasL
antibody (Fig. 7 f). In summary, these data demonstrate
that quantitatively and qualitatively distinct Ca21 signals can
differentially activate FasL/Fas versus perforin cytotoxicity.
Discussion
We have previously reported that distinct TCR signal
transduction pathways activate perforin versus FasL/Fas
killing (45, 46). This study demonstrated that soluble anti-
CD3e worked as effectively as Ag/MHC to trigger per-
forin killing by 14-7 (Fig. 1 a). This is most likely due to
the fact that L1210 expresses an FcR (64), which allows a
close physical proximity between the CTL and the target.
Cell to cell contact is required for the lethal hit as plate-
bound anti-CD3e was ineffective in triggering killing (Fig.
1), although it efficiently initiated granule exocytosis (Fig.
1 b). In comparison, soluble or plate-bound anti-CD3e or
Ag/MHC effectively induced FasL/Fas killing (Fig. 1 c),
leading us to believe that the physical interaction between
the CTL and the target is not as critical for FasL/Fas killing
as it is for perforin killing. In either case, anti-CD3e mim-
icked the effect of Ag/MHC in our 14-7/14-7FD system.
To further dissect the TCR signaling differences be-
tween 14-7 and 14-7FD, we examined Ca21 signaling in
the two clones. It was apparent that the TCR-triggered
Ca21 signal in 14-7FD was qualitatively and quantitatively
different from that of 14-7 (Fig. 2, a and b). 14-7 had a typ-
ical biphasic response, characterized by a large transient in-
crease followed by a sustained plateau phase (Fig. 2 a). In
contrast, 14-7FD did not have a biphasic response, but had
a small (50–100 nM), sustained increase (Fig. 2 b). Addi-
tionally the resting level of [Ca21]i in 14-7FD was consis-
tently higher than that in 14-7, ranging anywhere from 80
Figure 7. Demonstration in two additional CD81 CTL clones of nifid-
ipene inhibition of perforin cytolysis and thapsigargin induction of cytoly-
sis that is inhibited by anti-FasL. Clone 11-1 (a) and 14-13 (b) were pre-
treated for 40 min with nifedipine at various concentrations before the
start of a 51Cr–release assay. The CTLs were incubated with 0.10 mM
HA204–212 (a) or 0.01 mM nucleoprotein 147–155 (b) peptide–pulsed
L1210Fas2 targets (j) or L1210Fas1 targets (d) in a 51Cr–release assay (a
and b). Clones 11-1(j) and 14-13(d) were stimulated with PMA (25 ng/
ml) plus different doses of ionomycin (c) or thapsigargin (d) and granzyme
A granule exocytosis was determined. Clones 11-1(j) and 14-13(d)
were stimulated with 200, 20, or 2 nM of ionomycin (e) or thapsigargin
(f) and percentage of specific 51Cr–release of the L1210Fas1 target deter-
mined in the absence (j, d) or presence (h, s) of anti-FasL antibody.1064 Ca21 Signaling Modulates CTL Effector Functions
to 300 nM (Figs. 2 and 3). To determine if the slow in-
crease in [Ca21]i in 14-7FD was coming from intracellular
stores, extracellular influx, or both we examined the effect
of treating the CTL with EGTA before or after TCR trig-
gering. Adding EGTA before TCR engagement in 14-7
revealed that the large transient [Ca21]i increase is made up
of both intracellular (20%) and extracellular (80%) Ca21
(Fig. 2 c), whereas the plateau phase is made up of almost
entirely extracellular Ca21 influx (Fig. 2 e). Adding EGTA
before TCR stimulation almost completely inhibited the
Ca21 response in 14-7FD (Fig. 2 d), whereas adding EGTA
after stimulation revealed that a large component of the
Ca21 response was mediated by extracellular Ca21 influx
(Fig. 2 f). The 50–100-nM Ca21 response in 14-7FD is
near the limits of sensitivity of our instrument, and a small
but functional intracellular response such as a “Ca21 puff”
from the ER as has been described by M. Berridge (65) can
not be ruled out, especially considering that the Ca21 re-
sponse in 14-7 stimulated with low doses of thapsigargin
looks very similar to the TCR response in 14-7FD (Fig. 6
b). Nevertheless, the qualitatively and quantitatively distinct
Ca21 signaling patterns in 14-7FD make it a unique CTL
for examining the role Ca21 plays in activating and regulat-
ing CTL effector functions.
We next wanted to determine if the Ca21 signaling de-
fect in 14-7FD was at the level of activating intracellular
Ca21 release or if there was a defect in the Ca21 release–acti-
vated Ca21 influx pathway as has been described in mutant
Jurkat cells (66, 67). Using the Ca21 ATPase ER pump inhib-
itor thapsigargin, in the presence of EGTA demonstrated
that 14-7FD had a functional intracellular store of Ca21
(Fig. 3 a). Additionally, it could be demonstrated that re-
lease of Ca21 from this pool activated the Ca21 influx pathway
(Fig. 3 b). These results suggest that the signaling defect lies
upstream of ER Ca21 release along the pathway between
TCR stimulation, phospholipase C activation, and inositol
triphosphate production and binding.
Although it is apparent that differential TCR signaling is
occurring in 14-7FD, as of yet we do not know the reason
why. 14-7FD has equivalent levels of TCR, CD45, CD8a/b,
CD3e, zeta, Lck, Fyn, ZAP70, PLCg1, and MAPK (Esser,
M.T., unpublished observations), but we have not yet
tested the TCR-triggered activity of these known signaling
intermediates. One possible explanation for the signaling
defect in 14-7FD is that the higher resting level of [Ca21]i
modulates the activity of early TCR signaling kinases and
phosphatases, preventing “full activation”. Another explanation
is that a key signaling event such as zeta chain phosphoryla-
tion or Fyn kinase activation is not occurring in 14-7FD.
From other studies, we know that differential tyrosine ki-
nase activity occurs after TCR engagement in 14-7FD as
compared with 14-7 (Esser, M.T., unpublished observations).
How these early tyrosine kinase signaling events regulate
perforin versus FasL/Fas killing is not known.
Since FasL/Fas killing had originally been reported to be
Ca21 independent, we used our 14-7/14-7FD CTL to test
the intracellular Ca21 release and Ca21 influx requirements
for perforin/granule exocytosis and FasL/Fas killing. The L
type Ca21 channel antagonist verapamil had no effect on
perforin killing as had been seen by Gray et al. (68) or
FasL/Fas killing (data not shown). Interestingly, the L type
antagonist nifedipine inhibited perforin killing but not
FasL/Fas killing (Fig. 4). Our results confirm the findings
by Sitkovsky et al. that extracellular Ca21 is required for
granule exocytosis (41) and extend these observations by
characterizing the T type Ca21 channel antagonists NDGA
and SK&F-96365, both of which inhibited perforin killing.
The extracellular Ca21 requirement for granule exocytosis
is most likely due to the fact that the large initial increase in
[Ca21]i mediates the cytoskeletal changes required for gran-
ule exocytosis is comprised of 70–80% extracellular Ca21
(Fig. 2 c). These cytoskeletal changes occur at z200 nM,
can occur in the presence of CsA (69), and may explain
why perforin killing is CsA insensitive (46). We also found
that extracellular Ca21 is required for the induction of FasL
expression (Fig. 4 d) as well as FasL/Fas killing (Fig. 4 c).
These results extend the observations of Vignaux, who first
showed that Ca21 is required for the induction of FasL, but
once expressed, FasL/Fas killing is Ca21 independent (32).
From Fig. 4 d it appears that higher concentrations of the
antagonists are required to inhibit killing than are required
to inhibit expression of FasL. We do not find this surprising
in light of our findings and those of others, that neither the
level of FasL or Fas correlate with the levels of killing (20,
70, 71). Our data suggests that the initial peak of TCR-
stimulated increase in [Ca21]i is required for cytoskeletal
changes and perforin/granule exocytosis, whereas the sus-
tained influx is sufficient for calcineurin activation, NFATc
translocation to the nucleus, and FasL gene transcription.
Since PMA and ionomycin induced granzyme A exocy-
tosis in 14-7FD (Fig. 5), we wanted to determine if replac-
ing the increase in [Ca21]i (via ionomycin or thapsigargin)
in the presence of a TCR signal could induce perforin/
granule exocytosis. Using Ag/MHC or anti-CD3e plus
ionomycin or thapsigargin did not restored perforin/gran-
ule exocytosis killing in 14-7FD, suggesting that in addi-
tion to a strong Ca21 signal other signaling events lacking
in 14-7FD are required to induce perforin/granule exocy-
tosis killing (Fig. 5). Since we could restore perforin-medi-
ated cytotoxicity with PMA and ionomycin or thapsigargin
we asked if we could selectively induce FasL/Fas killing
without triggering perforin killing. Low doses of thapsigar-
gin induced FasL/Fas killing without triggering perforin/
granule exocytosis in 14-7 (Fig. 6 d). Concentrations of
thapsigargin which selectively activated FasL/Fas killing
were qualitatively different in the time course and extent to
which they increased [Ca21]i than were higher concentra-
tions that activated perforin killing. At lower concentra-
tions, thapsigargin induced a slow sustained increase in
[Ca21]i that looked very similar to the TCR-stimulated
changes in [Ca21]i in 14-7FD (Figs. 2 b and 6 b). These re-
sults suggest that qualitatively and quantitatively distinct
Ca21 signals can differentially activate CTL effector functions.
In addition to the quantitative and qualitative Ca21 sig-1065 Esser et al.
naling differences in 14-7FD, there could also be spatial
and temporal differences in Ca21 signaling. Studies per-
formed by Gray et al. revealed that following Ag/MHC
engagement, Ca21 mobilization from intracellular stores
occurred at a site distal to target cell contact and was tran-
sient (39), whereas extracellular Ca21 influx occurred prox-
imal to the T cell–target interface, was prolonged, and os-
cillated with a periodicity of 3–4 min (39). These early
studies demonstrate the need to examine the magnitude,
duration, and subcellular localization of the Ca21 response
in 14-7 and 14-7FD. These studies should provide new
understanding into the mechanisms of Ca21 regulated cyto-
toxicity and gene transcription.
In summary, our present findings demonstrate that sig-
naling via the TCR is a dynamic process, allowing per-
forin/granule exocytosis and FasL/Fas killing to be inde-
pendently activated. A large transient increase in [Ca21]i is
required for perforin killing, whereas sustained Ca21 influx
appears to be both necessary and sufficient for induction of
FasL/Fas killing. This differential Ca21 signaling allows se-
lective activation of FasL/Fas versus perforin killing and
may represent a mechanism that lymphocytes use to selec-
tively activate different effector functions, proliferation, or
death. By modulating these TCR signal transduction path-
ways, the immune system could selectively execute (per-
forin) or downregulate (FasL/Fas) a cellular immune re-
sponse.
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